MSA Capital
Signal active
Investment Firm
Overview
MSA Capital is a global venture capital and private equity firm that invests in technology-enabled companies from seed to growth stage. The firm manages capital from the world's top sovereign wealth funds, international asset managers, pension funds, university endowments, fund of funds, and family offices, as well as China's leading new economy entrepreneurs.
Highlights
Founded
2014
Industry
Financial Services
Employees
11-50
Investment
76
Lead Investment
23
Exits
11
Stages
Early Stage Venture, Late Stage Venture, Seed, Private Equity
Investor Type
Private Equity Firm, Venture Capital
Location
Asia
Contact Information
Social
Profile Resume
MSA Capital, established in 2014 and headquartered in Asia., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Financial Services, FinTech, Marketplace, Lending, Micro Lending, Consumer Lending, Venture Capital, Finance, B2B, Internet. The organization boasts a portfolio of 77 investments, with an average round size of $200.2M and 11 successful exits. Their recent investments include Jimubox, Matrix Partners China, Vertex Ventures, Xiaomi, Ventech China. The highest investment round they participated in was $1251.4B. Among their most notable exits are Jimubox and Matrix Partners China. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
MSA Capital has made 76 investments. Their most recent investment was on Jul 10, 2023, when Yanming Biology raised $96.8M.
MSA Capital has made 4 diversity investments. Their most recent diversity investment was on Dec 30, 2021, when Amador Bioscience raised $60.0M.
investments
76
Diversity investments
4
Lead investments
23
Number of exits
11
Investments
76
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Dec 29, 2022 | Life Biosciences | Biotechnology | 24.4M |
| Mar 31, 2023 | Shenji Changhua | Biotechnology | null |
| Jul 10, 2023 | Yanming Biology | Biotechnology | 96.8M |
| Jun 13, 2024 | - | - | 5.2M |
Exits
11
Funding Timeline
Funding rounds
76
Investors
1
Funds
4
Funding Rounds
76
MSA Capital has raised 76 rounds. Their latest funding was raised on Jun 13, 2024 from a Seed Round - XProtocol round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Dec 29, 2022 | Series A - Life Biosciences | - | 24.4M | - |
| Mar 31, 2023 | Angel Round - Shenji Changhua | - | 0 | - |
| Jul 10, 2023 | Series A - Yanming Biology | - | 96.8M | - |
| Jun 13, 2024 | Seed Round - XProtocol | - | 5.2M | - |
Investors
2
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Funding Round - MSA Capital | 0 |
| - | No | Secondary Market - MSA Capital | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.